Secondary Logo

Journal Logo

Smoking and Soft-Tissue Dermal Fillers: A Potentially Detrimental Combination?

Knobloch, Karsten M.D.; Vogt, Peter M. M.D., Ph.D.

Plastic and Reconstructive Surgery: July 2010 - Volume 126 - Issue 1 - p 345
doi: 10.1097/PRS.0b013e3181dab6db
LETTERS
Free

Plastic, Hand, and Reconstructive Surgery; Hannover Medical School; Hannover, Germany

Correspondence to Dr. Knobloch; Plastic, Hand, and Reconstructive Surgery; Hannover Medical School; Carl-Neuberg-Str. 1; 30625 Hannover, Germany; kknobi@yahoo.com

Back to Top | Article Outline

Sir:

We read with great interest the report by Rohrich et al. regarding complications when using soft-tissue fillers.1 Given the enormous increase in the use of soft-tissue filler injections, the complication rate is likely to increase. Besides biofilms, which are comprehensively addressed in Rohrich et al.'s stimulating special topic report, we believe that other patient-related risk factors should be highlighted in this regard as well. Dr. Rees and colleagues have reported in the Journal the detrimental effect of cigarette smoking on skin flap survival in the face lift patient.2 They reported on 1186 face lift procedures performed between 1975 and 1981, with a 10.2 percent total complication rate. Active smokers had a 12.5-fold increased risk for skin flap complications compared with nonsmokers. Notably, active smoking for more than 10 years leads to facial aging by 2.5 years, according to a comprehensive twin study from the Twins Day Festival in Twinsburg, Ohio, published in the Journal in 2009.3 In May of 2008, the Journal again reported four late infections after New-Fill injections in the cheek and lips in four female patients aged 48 years.4 All suffered late infections 2 to 6 months after filler injection, and all four women were active smokers. Notably, a recent case series with three female patients with alar necrosis following dermal filler injection did not comment on any smoking history that might have interfered with an altered nasal perfusion.5 Therefore, we would suggest physicians evaluate the smoking status of a given cosmetic customer before performing soft-tissue filler injections and, when in doubt, perform quantitative cotinine assays to estimate the risk for potential malperfusion. This is especially important among patients who have had previous surgical interventions, such as rhinoplasty or face lifts, with potentially altered vasculature.

Karsten Knobloch, M.D.

Peter M. Vogt, M.D., Ph.D.

Plastic, Hand, and Reconstructive Surgery

Hannover Medical School

Hannover, Germany

Back to Top | Article Outline

REFERENCES

1. Rohrich R, Monheit G, Nguyen AT, Brown SA, Fagien S. Soft-tissue filler complications: The important role of biofilms. Plast Reconstr Surg. 2010;125:1250–1256.
2. Rees TD, Liverett DM, Guy CL. The effect of cigarette smoking on skin-flap survival in the face lift patient. Plast Reconstr Surg. 1984;73:911–915.
3. Guyuron B, Rowe DJ, Weinfeld AB, Eshraghi Y, Fathi A, Iamphongsai S. Factors contributing to the facial aging of identical twins. Plast Reconstr Surg. 2009;123:1321–1331.
4. Goldan O, Garbov-Nardini G, Regev E, Orenstein A, Winkler E. Late-onset infections and granuloma formation after facial polylactic acid (New-Fill) injections in women who are heavy smokers. Plast Reconstr Surg. 2008;121:336e–337e.
5. Grunebaum LD, Bogdan Allemann I, Dayan S, Mandy S, Baumann L. The risk of alar necrosis associated with dermal filler injection. Dermatol Surg. 2009;35(Suppl 2):1635– 1640.

Section Description

GUIDELINES

Letters to the Editor, discussing material recently published in the Journal, are welcome. They will have the best chance of acceptance if they are received within 8 weeks of an article's publication. Letters to the Editor may be published with a response from the authors of the article being discussed. Discussions beyond the initial letter and response will not be published. Letters submitted pertaining to published Discussions of articles will not be printed. Letters to the Editor are not usually peer reviewed, but the Journal may invite replies from the authors of the original publication. All Letters are published at the discretion of the Editor.

Authors will be listed in the order in which they appear in the submission. Letters should be submitted electronically via PRS' enkwell, at www.editorialmanager.com/prs/.

We reserve the right to edit Letters to meet requirements of space and format. Any financial interests relevant to the content of the correspondence must be disclosed. Submission of a Letter constitutes permission for the American Society of Plastic Surgeons and its licensees and asignees to publish it in the Journal and in any other form or medium.

The views, opinions, and conclusions expressed in the Letters to the Editor represent the personal opinions of the individual writers and not those of the publisher, the Editorial Board, or the sponsors of the Journal. Any stated views, opinions, and conclusions do not reflect the policy of any of the sponsoring organizations or of the institutions with which the writer is affiliated, and the publisher, the Editorial Board, and the sponsoring organizations assume no responsibility for the content of such correspondence.

©2010American Society of Plastic Surgeons